Cargando…

Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578375/
https://www.ncbi.nlm.nih.gov/pubmed/37908271
http://dx.doi.org/10.1210/jcemcr/luac027
_version_ 1785121506327527424
collection PubMed
description
format Online
Article
Text
id pubmed-10578375
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105783752023-10-31 Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes” JCEM Case Rep Correction Oxford University Press 2022-12-28 /pmc/articles/PMC10578375/ /pubmed/37908271 http://dx.doi.org/10.1210/jcemcr/luac027 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction
Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
title Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
title_full Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
title_fullStr Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
title_full_unstemmed Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
title_short Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
title_sort correction to “glucagon-like peptide-1 receptor agonist treatment with semaglutide in type 1 diabetes”
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578375/
https://www.ncbi.nlm.nih.gov/pubmed/37908271
http://dx.doi.org/10.1210/jcemcr/luac027